CHITA – a registry of in vitro NAMs
In ADDC’s “Things I Wish I Knew” webinar series, we’ve been learning from prominent scientists, entrepreneurs, and investors about their successes, struggles, and the things they wished they knew before…
A recent paper from NTP showcases the application of mechanism-based NAMs for prediction of cardiotoxic potential. In a previous post, Getting Back on Track with NAMs at FDA, we encouraged…
A strong chain of translatability is crucial for successful drug discovery programs. The chain of translatability is a molecular-level association between the mechanisms that drive the assay phenotype, the preclinical disease…
